{
  "title": "Strategies to alleviate original antigenic sin",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY264",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Strategies to alleviate original antigenic sin",
  "performedBy": [
    {
      "firstName": "Joshy",
      "lastName": "Jacob",
      "email": "joshy.jacob@emory.edu",
      "affiliations": [
          {
             "name": "Emory Vaccine Center, Emory University"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "PBS_PBS_LV.FM1",
          "size": 1
        },
        {
          "name": "PBS_WI.FM1_LV.FM1",
          "size": 1
        },
        {
          "name": "WI.PR8_WI.FM1_LV.FM1",
          "size": 1
        },
        {
          "name": "WI.PR8_WI.FM1.PT_LV.FM1",
          "size": 1
        },
        {
          "name": "WI.PR8_WI.FM1.CpG_LV.FM1",
          "size": 1
        },
        {
          "name": "PBS_LV.FM1_LV.FM1",
          "size": 1
        },
        {
          "name": "LV.PR8_LV.FM1_LV.FM1",
          "size": 1
        },
        {
          "name": "LV.PR8_LV.FM1.PT_LV.FM1",
          "size": 1
        },
        {
          "name": "LV.PR8_LV.FM1.CpG_LV.FM1",
          "size": 1
        },
        {
          "name": "LV.PR8_LV.FM1.PT_LV.FM1",
          "size": 1
        },
        {
          "name": "LV.PR8_LV.FM1.CpG_LV.FM1",
          "size": 1
        },
        {
          "name": "PBS",
          "size": 1
        },
        {
          "name": "WI.PR8",
          "size": 1
        },
        {
          "name": "WI.PR8.PT",
          "size": 1
        },
        {
          "name": "WI.PR8.CpG",
          "size": 1
        },
        {
          "name": "WI.PR8_WI.FM1.NE_LV.FM1",
          "size": 1
        },
        {
          "name": "WI.PR8.NE_WI.FM1_LV.FM1",
          "size": 1
        },
        {
          "name": "PBS_WI.FM1.HA_FM1.AG",
          "size": 1
        },
        {
          "name": "WI.PR8.HA_WI.FM1.HA_LV.FM1",
          "size": 1
        },
        {
          "name": "PBS_WI.FM1_FM1.AG",
          "size": 1
        },
        {
          "name": "WI.PR8_WI.FM1_FM1.AG",
          "size": 1
        }
  ],
  
  "usesReagent": [
        {
          "name": "H1N1 influenza virus strain  A/FM/1/47"
        },
        {
          "name": "Phosphate Buffered Saline"
        },
        {
          "name": "H1N1 influenza virus strain A/PR/8/34"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "NA"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Joshy",
      "lastName": "Jacob",
      "email": "joshy.jacob@emory.edu",
      "affiliations": [
          {
             "name": "Emory Vaccine Center, Emory University"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Influenza Pathogenesis & Immunology Research Center (IPIRC)",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "HHSN266200700006C"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "The Influenza Pathogenesis & Immunology Research Center (IPIRC) is one of five national Influenza Centers of Excellence funded by NIH/NIAID. The goals of the Center are to determine the molecular, ecologic and/or environmental factors that influence the evolution, emergence, transmission and pathogenicity of influenza viruses, including studies on animal influenza viruses with pandemic potential; and to characterize the immune response to influenza vaccination to improve understanding of the immune correlates of protection and cross-protection. The Center's structure is comprised of four research projects, two pilot projects, and two training slots. The scope of the Center's focus includes planning for pandemic influenza and sharing data with other scientists in order to promote collaboration and lay the groundwork for new and improved methods of controlling influenza virus. In the event of a public health emergency involving the emergence and spread of an influenza pandemic in humans, the Network of Centers will be on the frontline to implement the NIAID Pandemic Public Health Research Response Plan.  https://www.fbo.gov/index?s=opportunity&mode=form&tab=core&id=da736a25c9098cee65ba909ab9c63121"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "22869731",
          "identifierSource": "pubmed"
        },
      "authorsList": "Kim JH(1), Davis WG, Sambhara S, Jacob J.",
      "title": "Strategies to alleviate original antigenic sin responses to influenza viruses.",
      "publicationVenue": "Proc Natl Acad Sci U S A.",
      "dates": [
        {
          "date": "2012",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Interventional"
      },
      {
        "value": "Infection Response"
      }
  ],
  "dates": [
      {
          "date": "2014-04-08",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Other"
        },
        "description": "lung viral titers by plaque assay",
        "types": [
            {
               "value": "Other"
            }
        ]
      },{
        "name": {
            "value": "Protein Quantification"
        },
        "description": "neutralizing-Ab titer",
        "types": [
            {
               "value": "Other"
            }
        ]
      },{
        "name": {
            "value": "Cellular Quantification"
        },
        "description": "analysis of Ag-specific T cells directly ex vivo by ELISPOT assay using immunodominant MHC class I? or class II?restricted peptides",
        "types": [
            {
               "value": "ELISPOT"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "NA"
        },
        {
          "name": "H-2d?restricted class I HA peptide IYSTVASSL-NA peptide TYQRTRALVRTGMDP"
        },
        {
          "name": "class II HA peptide"
        },
        {
          "name": "OVA(OT I-OT II)"
        },
        {
          "name": "PHA"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY264",
              "identifierSource": "ImmPort"
          },
          "title": "Strategies to alleviate original antigenic sin",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY264",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Influenza Pathogenesis & Immunology Research Center (IPIRC)",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "https://www.fbo.gov/?s=opportunity&mode=form&tab=core&id=380b2c8bd10fee1ebd65475f236dfd39&_cview=0"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "They explored strategies to overcome original antigenic sin responses in mice sequentially exposed to two closely related H1N1 influenza strains A/PR/8/34 and A/FM/1/47."
}
